The CYP1A2-164A→C polymorphism (CYP1A2*1F) is associated with the risk for colorectal adenomas in humans

Cancer Letters

Volumn 229, Issue 1, 2005, Pages 25-31

  Moonen, Harald ^a   Engels, Leopold ^b   Kleinjans, Jos ^a   De Kok, Theo ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b Sittard Geleen Heerlen   (Netherlands)

Author keywords

Adenomas; Colorectal cancer risk; CYP1A2; Heterocyclic aromatic amines; Polymorphism

Indexed keywords

ADENINE NUCLEOTIDE; AROMATIC AMINE; ARYLAMINE ACETYLTRANSFERASE; CYTOCHROME P450 1A2; HETEROCYCLIC AMINE; PYRIMIDINE NUCLEOTIDE; NAT2 PROTEIN, HUMAN;

ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; CANCER RISK; CANCER SIZE; CANCER SUSCEPTIBILITY; COLON CARCINOGENESIS; COLORECTAL ADENOMA; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; ENZYME METABOLISM; FEMALE; FOOD INTAKE; FOOD PROCESSING; GENOTYPE PHENOTYPE CORRELATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PHENOTYPIC VARIATION; PRIORITY JOURNAL; ADENOMA; CASE CONTROL STUDY; COLORECTAL TUMOR; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; MIDDLE AGED; PHENOTYPE; RISK FACTOR;

ADENOMA; ADULT; AGED; AGED, 80 AND OVER; ARYLAMINE N-ACETYLTRANSFERASE; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; CYTOCHROME P-450 CYP1A2; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 24344490679     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2004.12.010     Document Type: Article

References (40)

1. L.A. Cannon-Albright, M.H. Skolnick, D.T. Bishop, R.G. Lee, and R.W. Burt Common inheritance of susceptibility to colonic adenomatous polyps and associated colorectal cancers N. Engl. J. Med. 319 1988 533 537
2. D.M. Parkin, S.L. Whelan, J. Ferlay, L. Raymond, and J. Young Cancer Incidence in Five Continents vol. VII 1997 IARC Scientific Publications 143 Lyon
3. A.J. McMichael, and G.G. Giles Cancer in migrants to Australia: extending the descriptive epidemiological data Cancer Res. 48 1988 751 756
4. R. Doll, and R. Peto The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today J. Natl Cancer Inst. 66 1981 1191 1308
5. E. Giovannucci, E.J. Stampfer, G. Colditz, E.B. Rimm, and W.C. Willett Relationship of diet to risk of colorectal adenoma in men J. Natl Cancer Inst. 84 1992 91 98
6. S. Kono, K. Imanishi, K. Shinchi, and F. Yanai Relationship of diet to small and large adenomas of the sigmoid colon Jpn. J. Cancer. Res. 84 1993 13 19
7. R.A. Goldbohm, P.A. van den Brandt, P. van't Veer, H.A. Brants, E. Dorant, F. Sturmans, and R.J. Hermus A prospective cohort study on the relation between meat consumption and the risk of colon cancer Cancer Res. 54 1994 718 723
8. E. Giovannucci, E.B. Rimm, M.J. Stampfer, G.A. Colditz, A. Ascherio, and W.C. Willett Intake of fat, meat and fiber in relation to risk of colon cancer in men Cancer Res. 54 1994 2390 2397
9. M. Nagao, T. Ushijima, N. Watanabe, E. Okochi, M. Ochiai, H. Nakagama, and T. Sugimura Studies on mammary carcinogenesis induced by a heterocyclic amine, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, in mice and rats Environ. Mol. Mutagen. 39 2002 158 164
10. R.H. Adamson, U.P. Thorgeirsson, E.G. Snyderwine, S.S. Thorgeirsson, J. Reeves, and D.W. Dalgard Carcinogenicity of 2-amino-3-methylimidazo[4,5-f] quinoline in nonhuman primates: induction of tumors in three macaques Jpn. J. Cancer Res. 81 1990 10 14
11. M. Ochiai, K. Ogawa, K. Wakabayashi, T. Sugimura, S. Nagase, H. Esumi, and M. Nagao Induction of intestinal adenocarcinomas by 2-amino-1-methyl-6- phenylimidazo[4,5-b]pyridine in Nagase analbuminemic rats Jpn. J. Cancer Res. 82 1991 363 366
12. B. Vogelstein, E.R. Fearon, S.R. Hamilton, S.E. Kern, A.C. Preisinger, and M. Leppert Genetic alterations during colorectal-tumor development N. Engl. J. Med. 319 1988 525 532
13. H.J.J. Moonen, J.J. Briedé, J.M.S. van Maanen, J.C.S. Kleinjans, and T.M.C.M. de Kok Generation of free radicals and induction of DNA adducts by activation of heterocyclic aromatic amines via different metabolic pathways in vitro Mol. Carcinog. 35 2002 196 203
14. F.F. Kadlubar, K.R. Kaderlik, G.J. Mulder, D. Lin, M.A. Butler, and C.E. Teitel Metabolic activation and DNA adduct detection of PhIP in dogs, rats, and humans in relation to urinary bladder and colon carcinogenesis R.H. Adamson J-Å. Gustafsson I. Nobuyuki M. Nagao T. Sugimura K. Wakabayashi Y. Yamazoe Heterocyclic amines in cooked foods: possible human carcinogens 1995 1995 Princeton Scientific Publishing New York, NY 207 213
15. S.L. MacLeod, Y-M. Tang, T. Yokoi, T. Kamataki, S. Doublin, and B. Lawson The role of a recently discovered genetic polymorphism in the regulation of the human CYP1A2 gene Proc. Am. Assoc. Cancer Res. 39 1998 396
16. M. Nakajima, T. Yokoi, M. Mizutani, M. Kinoshita, M. Funayama, and T. Kamataki Genetic polymorphism in the 5′-flanking region of human CYP1A2 gene: effect on the CYP1A2 inducibility in humans J. Biochem. 125 1999 803 808
17. C. Sachse, J. Brockmöller, S. Bauer, and I. Roots Functional significance of a C→A polymorphism in intron I of the cytochrome P450 CYP1A2 gene tested with caffeine Br. J. Clin. Pharmacol. 47 1999 445 449
18. M.T. Landi, R. Sinha, N.P. Lang, and F.F. Kadlubar Human cytochrome P4501A2 P. Vineis N. Malats M. Lang Metabolic Polymorphisms and Susceptibility to Cancer 1999 IARC Scientific Publications 148 Lyon 173 195
19. S. MacLeod, R. Sinha, F.F. Kadlubar, and N.P. Lang Polymorphisms of CYP1A1 and GSTM1 influence the in vivo function of CYP1A2 Mutat. Res. 376 1997 135 142
20. T.M.C.M. De Kok, A. Van Faassen, B. Glinghammar, D.M.F.A. Pachen, M. Eng, and J.J. Rafter Bile acid concentrations, cytotoxicity, and pH of fecal water from patients with colorectal adenomas Dig. Dis. Sci. 44 1999 2218 2225
21. M.A. Doll, A.J. Fretland, A.C. Deitz, and D.W. Hein Determination of human NAT2 acetylator genotype by restriction fragment-length polymorphism and allele-specific amplification Anal. Biochem. 231 1995 413 420
22. K.P. Vatsis, W.W. Weber, D.A. Bell, J. Dupret, D.A. Price Evans, and D.M. Grant Nomenclature for N-acetyltransferases Pharmacogenetics 5 1995 1 17
23. L. Christiansen, A. Bygum, and A. Jensen Association between CYP1A2 polymorphism and susceptibility to porphyria cutanea tarda Hum. Genet. 107 2000 612 614
24. C. Krul, and G. Hageman Analysis of urinary caffeine metabolites to assess biotransformation enzyme activities by reverse-phase high-performance liquid chromatography J. Chrom. B 709 1998 27 34
25. C. Sachse, G. Smith, M.J.V. Wilkie, J.H. Barrett, R. Waxman, and F. Sullivan A pharmacogenetic study to investigate the role of dietary carcinogens in the etiology of colorectal cancer Carcinogenesis 23 2002 1839 1849
26. N. Ishibe, R. Sinha, D.W. Hein, M. Kulldorff, P. Strickland, and A.J. Fretland Genetic polymorphisms in heterocyclic amine metabolism and risk of colorectal adenomas Pharmacogenetics 12 2002 145 150
27. L. Le Marchand, J.H. Hankin, L.R. Wilkens, L.M. Pierce, A. Franke, and L.N. Kolonel Combined effects of well-done red meat, smoking, and rapid N-acetyltransferase 2 and CYP1A2 phenotypes in increasing colorectal cancer risk Cancer Epidemiol. Biomark. Prev. 10 2001 1259 1266
28. J.P. Gil, and M.C. Lechner Increased frequency of wild-type arylamine-N-acetyltransferase allele NAT2*4 homozygotes in Portuguese patients with colorectal cancer Carcinogenesis 19 1998 37 41
29. M.L. Slattery, J.D. Potter, W. Samowitz, J. Bigler, B. Caan, and M. Leppert NAT2, GSTM-1, cigarette smoking, and risk of colon cancer Cancer Epidemiol. Biomark. Prev. 7 1998 1079 1084
30. J. Chen, M.J. Stampfer, H.L. Hough, M. Garcia-Closas, W.C. Willett, and C.H. Hennekens A prospective study of N-acetyltransferase genotype, red meat intake, and risk of colorectal cancer Cancer Res. 58 1998 3307 3311
31. N.P. Lang, M.A. Butler, J. Massengill, M. Lawson, R. Craig Stotts, M. Hauer-Jensen, and F.F. Kadlubar Rapid metabolic phenotypes for acetyltransferase and cytochrome P4501A2 and putative exposure to food-borne heterocyclic amines increase the risk for colorectal cancer or polyps Cancer Epidemiol. Biomark. Prev. 3 1994 675 682
32. F.F. Kadlubar, M.A. Butler, K.R. Kaderlik, H.-C. Chou, and N.P. Lang Polymorphisms for aromatic amine metabolism in humans: relevance for human carcinogenesis Environ. Health Perspect. 98 1992 69 74
33. L. Le Marchand, J.H. Hankin, L.M. Pierce, R. Sinha, P.V. Nerurkar, and A.A. Franke Well-done red meat, metabolic phenotypes and colorectal cancer in Hawaii Mutat. Res. 506-507 2002 205 214
34. H.J.J. Moonen, E.J.C. Moonen, L. Maas, J.W. Dallinga, J.C.S. Kleinjans, and T.M.C.M. De Kok CYP1A2 and NAT2 genotype/phenotype relations and urinary excretion of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in a human dietary intervention study Fd. Chem. Toxicol. 42 2004 869 878
35. D.M. Grant, B.K. Tang, and W. Kalow A simple test for acetylator phenotype using caffeine Br. J. Clin. Pharmacol. 17 1984 459 464
36. D.W. Hein, M.A. Doll, A.J. Fretland, M.A. Leff, S.J. Webb, and G.H. Xiao Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms Cancer Epidemiol. Biomark. Prev. 9 2000 29 42
37. N.M. Probst-Hensch, R.W. Haile, S.A. Ingles, M.P. Longnecker, C.Y. Han, and B.K. Lin Acetylation polymorphisms and prevalence of colorectal adenomas Cancer Res. 55 1995 2017 2020
38. J.D. Potter, J. Bigler, L. Fosdick, R.M. Bostick, E. Kampman, C. Chen T.A. Louis, and P. Grambsch Colorectal adenomatous and hyperplastic polyps: smoking and N-acetyltransferase 2 polymorphisms Cancer Epidemiol. Biomark. Prev. 8 1999 69 75
39. C. Sachse, U. Bhambra, G. Smith, T.J. Lightfoot, J.H. Barrett, and J. Scollay Polymorphisms in the cytochrome P450 CYP1A2 gene (CYP1A2) in colorectal cancer patients and controls: allele frequencies, linkage disequilibrium and influence on caffeine metabolism Br. J. Clin. Pharmacol. 55 2003 68 76
40. K. Vistisen, S. Loft, and H.E. Poulsen Cytochrome P450 1A2 activity in man measured by caffeine metabolism: effect of smoking, broccoli and exercise Adv. Exp. Med. Biol. 283 1991 407 411